Skip to search boxSkip to navigationSkip to main content

Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease

  • Sandra Torres
    ,
  • Nuria Matías
    ,
  • Anna Baulies
    ,
  • Susana Nuñez
    ,
  • Cristina Alarcon-Vila
    ,
  • Laura Martinez
*Corresponding author for this work
  • CSIC - Institute of Biomedical Research of Barcelona
    ,
  • August Pi i Sunyer Biomedical Research Institute
    ,
  • Institut national de la santé et de la recherche médicale
    ,
  • Pontificia Universidad Católica de Chile
    ,
  • CSIC
    ,
  • University of Barcelona
Research Output:
Contribution to journal
Article
Research
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 60-72 (13 pages)

Journal (Volume, Issue Number)

Redox Biology (Volume 11)

Publication milestones

  • Published - 01/04/2017

Publication status

Published - 01/04/2017

ISSN

2213-2317

Publication IDs

  • Scopus: 84996844004
  • PubMed: 27888692

Abstract

Niemann Pick type C (NPC) disease is a progressive lysosomal storage disorder caused by mutations in genes encoding NPC1/NPC2 proteins, characterized by neurological defects, hepatosplenomegaly and premature death. While the primary biochemical feature of NPC disease is the intracellular accumulation of cholesterol and gangliosides, predominantly in endolysosomes, mitochondrial cholesterol accumulation has also been reported. As accumulation of cholesterol in mitochondria is known to impair the transport of GSH into mitochondria, resulting in mitochondrial GSH (mGSH) depletion, we investigated the impact of mGSH recovery in NPC disease. We show that GSH ethyl ester (GSH-EE), but not N-acetylcysteine (NAC), restored the mGSH pool in liver and brain of Npc1-/- mice and in fibroblasts from NPC patients, while both GSH-EE and NAC increased total GSH levels. GSH-EE but not NAC increased the median survival and maximal life span of Npc1-/- mice. Moreover, intraperitoneal therapy with GSH-EE protected against oxidative stress and oxidant-induced cell death, restored calbindin levels in cerebellar Purkinje cells and reversed locomotor impairment in Npc1-/- mice. High-resolution respirometry analyses revealed that GSH-EE improved oxidative phosphorylation, coupled respiration and maximal electron transfer in cerebellum of Npc1-/- mice. Lipidomic analyses showed that GSH-EE treatment had not effect in the profile of most sphingolipids in liver and brain, except for some particular species in brain of Npc1-/- mice. These findings indicate that the specific replenishment of mGSH may be a potential promising therapy for NPC disease, worth exploring alone or in combination with other options.

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
2.61

PlumX, opens in new tab

Captures
96
Citation count
66